Upadacitinib,Baricitinib
abbvie,eli lilly,Incyte
[]
lvv pearls carlo salvarani
2/2 #eular2023 sec works in #gca!: the titain trial sec vs atnf: observational study in tak, new kid on the block mavrelumab jaki: obs study of bari, upcoming rct for upada, but safety concerns in cvd 
Rheumatologist @NUSingapore @AIIMS_NewDelhi || Follow for #Rheum nuggets 🦴|| #MedEd || Mummy of 2 || Dreamer || Views my own 🇸🇬🇮🇳